To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
526
75 iu/day form cycle day 6
rFSH 150 iu/day
Anders Nyboe Andersen
Copenhagen, Copenhagen, Denmark
Ongoing pregnancy rate per started stimulation cycle
Time frame: ultrasound showing ongoing pregnancy
Ongoing pregnancy in subgroups of patients with lo0w serum LH levels
Time frame: ultrasound for ongoing pregnancy in subgroups
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.